Uterine Myomas and Treatments

Uterine myomas, also called leiomyomas or fibroids, are benign smooth-muscle tumors of the uterus that affect a substantial proportion of women of reproductive age and rank among the most common reasons for gynecological surgery. Researchers study their hormonal drivers—particularly the role of progesterone in promoting tumor growth—alongside a spectrum of interventions ranging from hysterectomy and myomectomy to minimally invasive options such as uterine artery embolization and MRI-guided focused ultrasound. A central challenge is balancing effective symptom relief against the preservation of fertility and quality of life, especially since some treatments carry meaningful tradeoffs for reproductive outcomes. Open questions include reliably distinguishing benign myomas from the rare but aggressive uterine sarcomas before surgery, and identifying which patients will respond best to specific treatment modalities based on tumor biology and epidemiological risk factors.

Works

70,577

Total citations

636,104

Keywords

Uterine LeiomyomaUterine FibroidsHysterectomyUterine SarcomasUterine Artery EmbolizationReproductive Outcomes